Tinea pedis treatment suit, tinea pedis treatment socks and liquid medicine

Abstract

The invention discloses a tinea pedis treatment suit, tinea pedis treatment socks and liquid medicine. The tinea pedis treatment suit comprises the tinea pedis treatment socks made of silica gel and the liquid medicine used for tinea pedis treatment. By adopting the tinea pedis treatment sock which can be tightly attached to the foot of the human body, has good elasticity and comfort and is made of the silica gel material, on one hand, the dosage of liquid medicine in each soaking treatment can reach the minimum, so that the use cost of the liquid medicine can be remarkably saved in the continuous long-time treatment process; on the other hand, in each soaking treatment process, a user can move freely by wearing the tinea pedis treatment sock made of the silica gel material, and other normal activities are not affected. Particularly, when long-time soaking treatment of more than 45 minutes is needed, the use experience of a user adopting the soaking treatment mode can be fundamentally improved.

Description

Technical Field

[0001] The present invention relates to the technical field of antibacterial and antimicrobial treatment, in particular to an antibacterial and antimicrobial product for treating tinea pedis. Background Art

[0002] Tinea pedis is a skin disease of the feet caused by pathogenic fungal infection. It is highly contagious and prevalent throughout the world, especially in tropical and subtropical regions. The drugs and methods used in the prior art for treating tinea pedis generally include sprays, ointments, and immersion treatments. Sprays and ointments are usually difficult to fully cover the entire foot and can only be applied locally. The drug's effective residence time on the foot is very short, and the fungus is difficult to effectively kill in a short period of time. Furthermore, because fungi are highly contagious and transmissible, sprays and ointments can usually only relieve itching but are difficult to effectively treat. Traditional immersion treatments and related products also have various shortcomings. Summary of the Invention

[0003] After consulting a large amount of clinical data on the treatment of tinea pedis, the inventors learned that because the soles of the feet and between the toes lack sebaceous glands, they lack fatty acids that resist skin filamentous fungi and have poor physiological defense functions. However, the skin sweat glands in these areas are very abundant, and sweating is frequent. In addition, the air circulation is poor and the local area is damp and warm, which easily leads to the growth of filamentous fungi. Because the stratum corneum of the skin on the soles of the feet is thick, the keratin in the stratum corneum is a rich nutrient for fungi, which is conducive to the storage and growth of fungi. However, fungi parasitize in the stratum corneum and continue to reproduce, requiring long-term medication to completely eliminate them. Since the metabolic cycle of human skin is about 28 days, the reasonable treatment duration should be one skin metabolic cycle, that is, about four weeks, and at least two weeks are required to achieve basic therapeutic effects.

[0004] The inventors further investigated and found that although the use of liquid immersion treatment can kill foot fungi more comprehensively, based on the above analysis, the traditional liquid immersion treatment method usually has at least the following two problems: On the one hand, there is the problem of choosing the medicine. If a strong liquid is selected, such as a tincture, it will kill the fungus at the cost of damaging the foot skin, so two or three immersion treatments can achieve the effect of treatment or even cure it; on the contrary, if a mild liquid is selected, such as an acetic acid liquid, although it will not cause damage to the foot skin, it generally requires more than several weeks of continuous treatment to achieve a good therapeutic effect. On the other hand, if a mild liquid is used, it requires a long treatment cycle (at least two weeks), so it is usually difficult for patients to adhere to the treatment. Even if the patient can adhere to continuous treatment, according to the traditional liquid immersion treatment method, because a large amount of liquid is required, it will greatly increase the financial burden on the patient.

[0005] In addition, through repeated experimental research, the inventors discovered that there is a key factor that affects the therapeutic effect of the medicinal liquid immersion treatment method, which is the length of time for each immersion treatment. Specifically, if a mild medicinal liquid is used for immersion treatment, each immersion treatment time must be more than 45 minutes to achieve a good therapeutic effect. Such a long time will inevitably impose significant restrictions on the user's normal activities. Although there is also a method in the prior art that uses a disposable plastic bag filled with medicinal liquid and then put on the foot, this method is difficult to achieve the minimum dosage of medicine on the one hand; on the other hand, more importantly, this method cannot effectively solve the problem of limited movement of the user during the immersion treatment.

[0006] In order to solve the above problems, the embodiments of the present application provide an tinea pedis treatment kit, an tinea pedis treatment sock and a liquid medicine.

[0007] In a first aspect, an embodiment of the present application provides a tinea pedis treatment kit comprising:

[0008] Tinea pedis treatment socks, the tinea pedis treatment socks are made of silicone material as a whole, and when the tinea pedis treatment socks are put on the human foot, they can form a tight fit with the human foot;

[0009] A liquid medicine for treating tinea pedis, wherein the liquid medicine is filled in a sub-bottle / bag with a capacity of 20 to 30 ml, and the dosage of the liquid medicine in each sub-bottle / bag is equivalent to the capacity of the sub-bottle / bag;

[0010] Wherein, when the tinea pedis therapeutic socks are in use, the dosage of the medicinal liquid required to be added to one tinea pedis therapeutic sock each time is the dosage of the medicinal liquid in one of the sub-packaging bottles / bags.

[0011] In a second aspect, an embodiment of the present application provides a tinea pedis treatment kit comprising:

[0012] Tinea pedis treatment socks, the tinea pedis treatment socks are made of silicone material as a whole, and when the tinea pedis treatment socks are put on the human foot, they can form a tight fit with the human foot;

[0013] A liquid medicine for treating tinea pedis, wherein the liquid medicine is filled in a sub-bottle / bag with a capacity of 40 to 60 ml, and the dosage of the liquid medicine in each sub-bottle / bag is equivalent to the capacity of the sub-bottle / bag;

[0014] Wherein, when the tinea pedis therapeutic socks are in use, the dosage of the medicinal liquid required to be added to one tinea pedis therapeutic sock is half the dosage of the medicinal liquid in one of the sub-packaging bottles / bags.

[0015] In a third aspect, an embodiment of the present application provides a tinea pedis treatment kit comprising:

[0016] Tinea pedis treatment socks, the tinea pedis treatment socks are made of silicone material as a whole, and when the tinea pedis treatment socks are put on the human foot, they can form a tight fit with the human foot;

[0017] A medicinal solution for treating tinea pedis, wherein the medicinal solution is filled in a sub-packaging bottle or bag with a capacity of 300 to 600 ml;

[0018] Wherein, when the tinea pedis treatment socks are used, the dosage of the medicinal solution required to be added to one tinea pedis treatment sock each time is 15 to 30 ml.

[0019] In a fourth aspect, an embodiment of the present application provides a tinea pedis treatment sock, which can be used as the tinea pedis treatment sock of the tinea pedis treatment kit described in the first, second, and third aspects above. The tinea pedis treatment sock is made of a silicone material, and the silicone material is mixed with 0.3-0.8 parts by weight of the silver ion antibacterial agent, and the silver ion concentration in the silver ion antibacterial agent is 1000-2000ppm.

[0020] In a fourth aspect, a medicinal solution for treating tinea pedis provided in an embodiment of the present application can be used as the medicinal solution of the tinea pedis treatment kit described in the first, second, and third aspects above. The main active ingredient of the medicinal solution is acetic acid, and the acetic acid concentration is 10±2%.

[0021] The beneficial effect of the technical solution of the embodiment of the present application is that, by adopting a tinea pedis treatment sock made of silicone material with good elasticity and comfort that can form a close fit with the human foot, on the one hand, the dosage of the liquid medicine used during each immersion treatment can be minimized, thereby significantly saving the cost of the liquid medicine during a continuous long treatment process; on the other hand, during each immersion treatment process, wearing such a silicone tinea pedis treatment sock can ensure that the user can move freely without affecting other normal activities, especially when a long immersion treatment of more than 45 minutes is required, it can fundamentally improve the user's experience of using such an immersion treatment method. The liquid medicine is divided into 20-30ml sub-bottles / bags or 40-60ml sub-bottles / bags, and it is possible to pour 20-30ml of a sub-bottle / bag of liquid medicine into each tinea pedis treatment sock each time, or pour 40-60ml of a sub-bottle / bag of liquid medicine into two tinea pedis treatment socks each time, which can facilitate the user to accurately grasp the dosage of each foot each time in actual use. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is a schematic diagram of the tinea pedis treatment kit in use according to an embodiment of the present application.

[0023] Figure 1: tinea pedis treatment socks, 2. Medicinal solution for treating tinea pedis, 3. Human foot. DETAILED DESCRIPTION

[0024] Tinea pedis is a stubborn disease of the foot skin caused by filamentous fungal infection. Because the stratum corneum of the soles of the feet is thicker, and the filamentous fungi parasitize in the stratum corneum to grow and reproduce, and because the human skin metabolism cycle is generally about four weeks, the use of liquid immersion treatment generally requires about four weeks of continuous treatment, and each time the liquid must be retained in the tinea pedis affected area for a long enough time (generally one hour is appropriate) to effectively kill the filamentous fungi in the stratum corneum of the skin. In other words, usually only in a complete skin metabolism cycle, the growth and reproduction of filamentous fungi is continuously suppressed by antibacterial liquid, until the foot skin undergoes natural metabolism and renewal, the filamentous fungi growing in the stratum corneum of the skin will be completely eliminated, and this highly contagious fungus can be effectively prevented from resurfacing within a skin metabolism cycle. Therefore, the treatment of tinea pedis is not only a problem of drug selection and use, but also a problem of cognition and method.

[0025] For most patients who suffer from long-term, unresolved tinea pedis, the first common problem is a misunderstanding of its treatment. Most people assume that tinea pedis is simply a bacterial infection on the surface of the foot that infects the skin, and that simply killing the bacteria will naturally resolve it. While this understanding appears correct, many people don't realize that these bacteria, called filamentous fungi, can hide deep within the fine lines of the skin. Standard sprays or lotions rarely kill these filamentous fungi in a short period of time, requiring continuous medication for a full skin metabolism cycle, or approximately one month, to completely eradicate them. The second problem is treatment. Due to this misunderstanding, many people fail to realize the crucial role of continuous medication for a full skin metabolism cycle in treating tinea pedis. More importantly, even if they know this, how can they maintain medication for a full skin metabolism cycle, nearly a month, without restricting or inconveniencing their daily lives or imposing an excessive financial burden?

[0026] The technical contribution of the technical solution of the present application mainly lies in, but is not limited to, providing users with a set of problem-solving solutions, namely, by combining the tinea pedis treatment socks, which are made of silicone material as a whole and can form a tight fit with the human foot when put on the human foot, with the liquid medicine for treating tinea pedis. On the one hand, it can effectively avoid causing significant restrictions on the user's normal activities during the immersion treatment process; on the other hand, because the tinea pedis treatment socks that form a tight fit with the human foot can minimize the amount of medicine used, even long-term continuous treatment will not excessively increase the user's medication costs.

[0027] Figure 1 This is a schematic diagram of the tinea pedis treatment kit in use according to an embodiment of the present application.

[0028] like Figure 1As shown, Example 1 of the present application provides a tinea pedis treatment kit, comprising:

[0029] A tinea pedis treatment sock 1, the tinea pedis treatment sock 1 is made entirely of silicone material, and when the tinea pedis treatment sock 1 is put on a human foot 3, it can form a tight fit with the human foot 3;

[0030] Liquid 2 for treating tinea pedis, the liquid being filled in sub-bottles / bags with a capacity of 20 to 30 ml, the dosage of the liquid in each sub-bottle / bag being equivalent to the capacity of the sub-bottle / bag;

[0031] When the tinea pedis therapeutic socks 1 are in use, the dosage of the medicinal solution 2 required to be added to one tinea pedis therapeutic socks 1 each time is the dosage of the medicinal solution in one of the sub-packaging bottles / bags.

[0032] In some embodiments, the tinea pedis treatment kit includes a pair of the tinea pedis treatment socks 1 and 20 to 40 sub-bottles / bags containing the liquid medicine. Further optionally, the capacity of the sub-bottle / bag is 25 ml, and the number of the sub-bottles / bags is 20.

[0033] like Figure 1 As shown, when the tinea pedis treatment sock 1 is placed on a human foot 3, it forms a tight fit with the human foot 3. This allows the drug solution 2 to fully penetrate a large area of the foot skin, minimizing the dosage of the drug, thereby achieving the beneficial effect of not excessively increasing the user's medication costs even for long-term continuous treatment. By selecting a silicone material that is both elastic and comfortable as the base material for the tinea pedis treatment sock 1, the above-mentioned technical effect of forming a tight fit with the human foot 3 can be fully achieved.

[0034] It will be understood by those skilled in the art that if the tinea pedis treatment socks 1 of the embodiment of the present application are made of natural latex or a material similar to silicone that is both elastic and comfortable to wear, and are used in conjunction with the corresponding medicinal solution 2 for treating tinea pedis, it should also be within the scope of protection disclosed in the technical solution of the embodiment of the present application.

[0035] In Example 1 of the present application, the liquid medicine 2 for treating tinea pedis is filled in a sub-bottle / bag with a capacity of 20 to 30 ml. Taking a 25 ml sub-bottle as an example, the dosage of the liquid medicine in the bottle is equivalent to the capacity of the sub-bottle, which is also about 25 ml. When using the tinea treatment socks 1 for liquid medicine soaking treatment, the dosage of the liquid medicine 2 required to be added to a tinea pedis treatment sock 1 each time is exactly the dosage of the liquid medicine contained in the sub-bottle. This precise configuration of the dosage of the liquid medicine in the sub-bottle can facilitate users to accurately grasp the dosage of each foot each time in actual use. It will not cause insufficient dosage of liquid medicine to make it difficult to achieve a good effect of soaking treatment, nor will it cause excessive dosage of liquid medicine to cause overflow of liquid medicine during use. On the other hand, by accurately controlling the dosage of the medicine, it can also effectively avoid the situation where the user's medication costs are excessively increased during long-term continuous treatment.

[0036] Example 2 of the present application provides a tinea pedis treatment kit. The main difference from Example 1 is that the medicinal liquid 2 is filled in a sub-bottle / bag with a capacity of 40 to 60 ml. When used, the dosage of the medicinal liquid required to be added to an tinea pedis treatment sock 1 each time is half the dosage of the medicinal liquid in a sub-bottle / bag.

[0037] In some embodiments, the tinea pedis treatment kit includes a pair of tinea pedis treatment socks 1 and 10 to 20 sub-bottles / bags containing the liquid medicine. Optionally, the sub-bottles / bags have a capacity of 50 ml, are in a quantity of 10, and have scale marks on them.

[0038] In Example 2 of the present application, the medicinal solution 2 for treating tinea pedis is filled into a 40-60ml bottle or bag. Taking a 50ml bottle as an example, the dosage of the medicinal solution in the bottle is equivalent to the bottle's capacity, also approximately 50ml. When using the tinea pedis treatment sock 1 for medicinal solution immersion treatment, the dosage of the medicinal solution 2 required for each tinea pedis treatment sock 1 is half the dosage of the medicinal solution in a 50ml bottle.

[0039] If the sub-bottle has a capacity of 50 ml, the sub-bottle may be provided with a scale with the smallest unit of 5 ml, or at least with a scale indicating half the capacity of the bottle, to ensure that exactly half a bottle of liquid medicine 2 is poured into each tinea pedis treatment sock 1 during use. This precise configuration of the dosage of the sub-bottle liquid medicine in this embodiment is also used to facilitate the user to accurately determine the dosage of the medicine for each foot during actual use.

[0040] Example 3 of the present application provides a tinea pedis treatment kit. The main difference from Examples 1 and 2 is that the medicinal liquid 2 is filled in a sub-bottle / bag with a capacity of 300 to 600 ml. When used, the dosage of the medicinal liquid 2 required to be added to an tinea pedis treatment sock 1 each time is 15 to 30 ml.

[0041] In some embodiments, the capacity of the sub-packaging bottle / bag is 500 ml. When the tinea pedis therapeutic socks 1 are used, the dosage of the medicinal solution 2 required to be added to one tinea pedis therapeutic sock 1 each time is 25 ml.

[0042] In Examples 1, 2, and 3 of the present application, optionally, a toe cover for being put on a toe alone is further included, wherein the toe cover is made entirely of silicone material, and when the toe cover is put on the toe, the cover opening fits tightly against the toe, and there is at least 2 ml of space between the cover body and the toe for accommodating the medicinal solution.

[0043] In Examples 1, 2, and 3 of the present application, the main active ingredient of the medicinal solution 2 is acetic acid, and the acetic acid concentration thereof is between 6% and 20%.

[0044] Optionally, the acetic acid concentration of the drug solution 2 is 10±2%.

[0045] Optionally, the medicinal solution 2 further comprises 0.1-1 parts by weight of Zanthoxylum bungeanum extract.

[0046] Optionally, the medicinal solution 2 further comprises 0.1-1 parts by weight of Phellodendron amurense extract.

[0047] Optionally, the liquid medicine 2 further comprises 0.1-1 parts by weight of alum.

[0048] Optionally, the medicinal solution 2 further comprises 0.1-1 parts by weight of Phellodendron amurense extract and 0.1-1 parts by weight of alum.

[0049] In Examples 1, 2, and 3 of the present application, the tinea pedis treatment socks 1 contain 0.3-0.8 parts by weight of a silver ion antibacterial agent, and the silver ion concentration in the silver ion antibacterial agent is 1000-2000 ppm.

[0050] Optionally, the tinea pedis treatment socks contain 0.6±0.1 parts by weight of the silver ion antibacterial agent.

[0051] The present application also provides an embodiment of an tinea pedis treatment sock that can be used in the tinea pedis treatment kits described in embodiments 1, 2, and 3 above. The tinea pedis treatment sock 1 is made of a silicone material, and the silicone material is mixed with 0.3-0.8 parts by weight of a silver ion antibacterial agent, wherein the silver ion concentration of the silver ion antibacterial agent is 1000-2000 ppm. Optionally, the silicone material is mixed with 0.6±0.1 parts by weight of the silver ion antibacterial agent.

[0052] This embodiment of the present application also provides a medicinal solution 2 for treating tinea pedis, which can be used in the tinea pedis treatment kits described in Examples 1, 2, and 3 above. The main active ingredient of the medicinal solution 2 is acetic acid, and the acetic acid concentration is 10±2%. Optionally, the medicinal solution 2 also includes 0.1-1 parts by weight of a Zanthoxylum bungeanum extract, 0.1-1 parts by weight of a Phellodendron amurense extract, and / or 0.1-1 parts by weight of alum.

[0053] It should be understood that the above-mentioned specific implementation methods or embodiments of the present application are merely used to illustrate or explain the technical principles of the technical solutions of the present application for solving related technical problems, and do not constitute a limitation of the present application. Therefore, any modifications, equivalent substitutions, improvements, etc. made without departing from the spirit and scope of the present application should be included in the scope of protection of the present application. In addition, the claims attached to the present application are intended to cover all changes and modifications that fall within the scope and boundaries of the attached claims, or within the equivalent forms of such scope and boundaries.

Claims

1. A tinea pedis treatment kit comprising: Tinea pedis treatment socks, the tinea pedis treatment socks are made of silicone material as a whole, and when the tinea pedis treatment socks are put on the human foot, they can form a tight fit with the human foot; A liquid medicine for treating tinea pedis, wherein the liquid medicine is filled in a sub-bottle / bag with a capacity of 20 to 30 ml, and the dosage of the liquid medicine in each sub-bottle / bag is equivalent to the capacity of the sub-bottle / bag; Wherein, when the tinea pedis therapeutic socks are in use, the dosage of the medicinal liquid required to be added to one tinea pedis therapeutic sock each time is the dosage of the medicinal liquid in one of the sub-packaging bottles / bags.

2. The tinea pedis treatment kit according to claim 1, wherein: The tinea pedis treatment kit comprises a pair of tinea pedis treatment socks and 20 to 40 sub-packaging bottles / bags containing the liquid medicine.

3. The tinea pedis treatment kit according to claim 2, wherein: The capacity of the sub-packaging bottle / bag is 25 ml, and the number of the sub-packaging bottles / bags is 20.

4. A tinea pedis treatment kit comprising: Tinea pedis treatment socks, the tinea pedis treatment socks are made of silicone material as a whole, and when the tinea pedis treatment socks are put on the human foot, they can form a tight fit with the human foot; A liquid medicine for treating tinea pedis, wherein the liquid medicine is filled in a sub-bottle / bag with a capacity of 40 to 60 ml, and the dosage of the liquid medicine in each sub-bottle / bag is equivalent to the capacity of the sub-bottle / bag; Wherein, when the tinea pedis therapeutic socks are in use, the dosage of the medicinal liquid required to be added to one tinea pedis therapeutic sock is half the dosage of the medicinal liquid in one of the sub-packaging bottles / bags.

5. The tinea pedis treatment kit according to claim 4, wherein: The tinea pedis treatment kit comprises a pair of tinea pedis treatment socks and 10 to 20 sub-packaging bottles / bags containing the liquid medicine.

6. The tinea pedis treatment kit according to claim 5, wherein: The capacity of the sub-packaging bottle / bag is 50 ml, the number of the sub-packaging bottles / bags is 10, and the sub-packaging bottle / bag has a scale.

7. A tinea pedis treatment kit comprising: Tinea pedis treatment socks, the tinea pedis treatment socks are made of silicone material as a whole, and when the tinea pedis treatment socks are put on the human foot, they can form a tight fit with the human foot; A medicinal solution for treating tinea pedis, wherein the medicinal solution is filled in a sub-packaging bottle or bag with a capacity of 300 to 600 ml; Wherein, when the tinea pedis treatment socks are used, the dosage of the medicinal solution required to be added to one tinea pedis treatment sock each time is 15 to 30 ml.

8. The tinea pedis treatment kit according to claim 7, wherein: The capacity of the sub-packaging bottle / bag is 500 ml. When the tinea pedis therapeutic socks are used, the dosage of the medicinal solution required to be added to one tinea pedis therapeutic sock each time is 25 ml.

9. The tinea pedis treatment kit according to claim 1, 4 or 7, further comprising: A toe cover is used to be put on a toe alone. The toe cover is made of silicone material as a whole. When the toe cover is put on the toe, the cover mouth fits tightly against the toe, and there is at least 2 ml of the liquid medicine accommodating space between the cover body and the toe.

10. The tinea pedis treatment kit according to claim 1, 4 or 7, wherein: The main active ingredient of the medicinal solution is acetic acid, and the acetic acid concentration is 6-20%.

11. The tinea pedis treatment kit according to claim 10, wherein: The acetic acid concentration of the liquid medicine is 10±2%.

12. The tinea pedis treatment kit according to claim 1, 4 or 7, wherein: The medicinal solution also includes 0.1-1 parts by weight of Zanthoxylum bungeanum extract.

13. The tinea pedis treatment kit according to claim 12, wherein: The medicinal solution further comprises 0.1-1 parts by weight of Phellodendron amurense extract and / or 0.1-1 parts by weight of alum.

14. The tinea pedis treatment kit according to claim 1, 4 or 7, wherein: The tinea pedis therapeutic socks contain 0.3-0.8 parts by weight of a silver ion antibacterial agent, and the silver ion concentration in the silver ion antibacterial agent is 1000-2000 ppm.

15. The tinea pedis treatment kit according to claim 14, wherein: The tinea pedis treating socks contain 0.6±0.1 parts by weight of the silver ion antibacterial agent.

16. A tinea pedis treatment sock that can be used in the tinea pedis treatment kit described in claim 1, 4 or 7, wherein the tinea pedis treatment sock is made of a silicone material, and the silicone material is mixed with 0.3-0.8 parts by weight of the silver ion antibacterial agent, and the silver ion concentration in the silver ion antibacterial agent is 1000-2000 ppm.

17. The tinea pedis therapeutic socks according to claim 16, wherein: The silica gel material is mixed with 0.6±0.1 parts by weight of the silver ion antibacterial agent.

18. A medicinal solution for treating tinea pedis, which can be used in the tinea pedis treatment kit according to claim 1, 4 or 7, wherein the main active ingredient of the medicinal solution is acetic acid, and the acetic acid concentration is 10±2%.

19. The medical solution according to claim 18, wherein The medicinal solution further comprises 0.1-1 parts by weight of Zanthoxylum bungeanum extract, 0.1-1 parts by weight of Phellodendron amurense extract and / or 0.1-1 parts by weight of alum.

Images